“Efficacy and Safety Results of Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: 16-Week Results From SPROUT, a Phase 3, Randomized, Controlled Study”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s109. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/1982.